Spatial Transcriptomics Identifies Expression Signatures Specific to Lacrimal Gland Adenoid Cystic Carcinoma Cells

Area of Science:

• Oncology
• Genomics
• Ophthalmology

Background:

• Lacrimal gland adenoid cystic carcinoma (LGACC) is a rare but aggressive malignancy with poor survival rates.
• Current treatments involving eye removal and chemoradiation have limited efficacy due to high recurrence and metastasis rates.
• The complex pathobiology of LGACC remains poorly understood, hindering effective diagnosis and management.

Purpose of the Study:

• To identify a specific LGACC gene signature using integrated transcriptomic approaches.
• To understand the molecular and cellular landscape of LGACC.
• To inform the development of novel targeted therapies for LGACC.

Main Methods:

• Integration of bulk RNA sequencing (RNA-seq) and spatial transcriptomics.
• Differential gene expression analysis to identify LGACC-specific genes.
• Pathway analysis to elucidate activated signaling cascades.

Main Results:

• Identified 3499 differentially expressed genes via bulk RNA-seq.
• Spatial transcriptomics revealed 15 upregulated and 12 downregulated genes specific to LGACC cells.
• Discovered a transitional state/stem cell cluster and identified upregulation of PI3K-Akt and IL-17 signaling pathways.

Conclusions:

• The study elucidates the molecular and cellular characteristics of LGACC.
• A specific LGACC gene signature has been identified.
• Findings pave the way for developing targeted therapies to improve patient outcomes.